{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T10:44:09Z","timestamp":1770979449925,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T00:00:00Z","timestamp":1707350400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019155","name":"Nanjing University Medical School Affiliated Nanjing Drum Tower Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019155","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008048","name":"Nanjing University","doi-asserted-by":"publisher","award":["2023-LCYJ-PY-25"],"award-info":[{"award-number":["2023-LCYJ-PY-25"]}],"id":[{"id":"10.13039\/501100008048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.cbi.2024.110906","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T12:18:46Z","timestamp":1707394726000},"page":"110906","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pharmacokinetic interactions between tacrolimus and Wuzhi capsule in liver transplant recipients: Genetic polymorphisms affect the drug interaction"],"prefix":"10.1016","volume":"391","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6216-8648","authenticated-orcid":false,"given":"Siqi","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangmiao","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuanchen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3659-1282","authenticated-orcid":false,"given":"Huaijun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2024.110906_bib1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/00007890-199801150-00004","article-title":"A tacrolimus-related immunosuppressant with biochemical properties distinct from those of tacrolimus","volume":"65","author":"Peterson","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.cbi.2024.110906_bib2","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1080\/17425255.2020.1803277","article-title":"Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives","volume":"16","author":"Degraeve","year":"2020","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.cbi.2024.110906_bib3","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/11317350-000000000-00000","article-title":"Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I","volume":"49","author":"Staatz","year":"2010","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.cbi.2024.110906_bib4","first-page":"441","article-title":"Combinational Effect of CYP3A5 and MDR-1 polymorphisms on tacrolimus pharmacokinetics in liver transplant patients","volume":"13","author":"Buend\u00eda","year":"2015","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.cbi.2024.110906_bib5","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1002\/phar.1928","article-title":"Influence of ABCC2, CYP2C8, and CYP2J2 polymorphisms on tacrolimus and mycophenolate sodium-based treatment in brazilian kidney transplant recipients","volume":"37","author":"Genvigir","year":"2017","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cbi.2024.110906_bib6","first-page":"1893","article-title":"Effect of CYP3A4 and PPARA polymorphism on concentration-to-dose ratio and adverse effects of tacrolimus in Pakistani liver transplant recipients","volume":"38","author":"Azam","year":"2022","journal-title":"Pakistan J. Med. Sci."},{"key":"10.1016\/j.cbi.2024.110906_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12072-022-10401-z","article-title":"Impact of single-nucleotide polymorphisms on tacrolimus pharmacokinetics in liver transplant patients after switching to once-daily dosing","volume":"17","author":"Park","year":"2023","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cbi.2024.110906_bib8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1038\/aps.2016.77","article-title":"The POR rs1057868-rs2868177 GC-GT diplotype is associated with high tacrolimus concentrations in early post-renal transplant recipients","volume":"37","author":"Liu","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.cbi.2024.110906_bib9","first-page":"1668","article-title":"Increase in tacrolimus exposure after steroid tapering is influenced by CYP3A5 and pregnane X receptor genetic polymorphisms in renal transplant recipients","volume":"33","author":"Stifft","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.cbi.2024.110906_bib10","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1124\/dmd.114.062067","article-title":"Therapeutic efficacy of Wuzhi tablet (Schisandra sphenanthera Extract) on acetaminophen-induced hepatotoxicity through a mechanism distinct from N-acetylcysteine","volume":"43","author":"Fan","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2024.110906_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1045843","article-title":"Plasma metabolomic profiling reveals factors associated with dose-adjusted trough concentration of tacrolimus in liver transplant recipients","volume":"13","author":"Zhu","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110906_bib12","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s11255-014-0801-3","article-title":"Co-administration of Wuzhi capsules and tacrolimus in patients with idiopathic membranous nephropathy: clinical efficacy and pharmacoeconomics","volume":"46","author":"Sun","year":"2014","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.cbi.2024.110906_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1080\/00498254.2022.2073851","article-title":"Population pharmacokinetics and dosage optimisation of tacrolimus coadministration with Wuzhi capsule in adult liver transplant patients","volume":"52","author":"Du","year":"2022","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2024.110906_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.phymed.2012.11.008","article-title":"Effect of long-term co-administration of Wuzhi tablet (Schisandra sphenanthera extract) and prednisone on the pharmacokinetics of tacrolimus","volume":"20","author":"Qin","year":"2013","journal-title":"Phytomedicine"},{"key":"10.1016\/j.cbi.2024.110906_bib15","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1111\/jcpt.13493","article-title":"Effects and safety evaluation of Wuzhi Capsules combined with tacrolimus for the treatment of kidney transplantation recipients","volume":"46","author":"Cheng","year":"2021","journal-title":"J. Clin. Pharm. Therapeut."},{"key":"10.1016\/j.cbi.2024.110906_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1111\/bcpt.12914","article-title":"Prediction of drug-drug interaction between tacrolimus and principal ingredients of wuzhi capsule in Chinese healthy volunteers using physiologically-based pharmacokinetic modelling","volume":"122","author":"Zhang","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.cbi.2024.110906_bib17","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3390\/ph14030198","article-title":"Investigation of the impact of CYP3A5 polymorphism on drug-drug interaction between tacrolimus and schisantherin A\/schisandrin A based on physiologically-based pharmacokinetic modeling","volume":"14","author":"He","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.cbi.2024.110906_bib18","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/pharmaceutics13030371","article-title":"Inhibitory effects of schisandra lignans on cytochrome P450s and uridine 5\u2019-diphospho-glucuronosyl transferases in human liver microsomes","volume":"13","author":"Seo","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2024.110906_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.fitote.2017.03.010","article-title":"Inhibition of human CYP3A4 and CYP3A5 enzymes by gomisin C and gomisin G, two lignan analogs derived from Schisandra chinensis","volume":"119","author":"Zhao","year":"2017","journal-title":"Fitoterapia"},{"key":"10.1016\/j.cbi.2024.110906_bib20","volume":"13","author":"Zhang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110906_bib21","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1111\/cts.13065","article-title":"Association of CYP3A5 polymorphisms and parathyroid hormone with blood level of tacrolimus in patients with end-stage renal disease","volume":"14","author":"Tanaka","year":"2021","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.cbi.2024.110906_bib22","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/bcp.12747","article-title":"Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients","volume":"80","author":"Monostory","year":"2015","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110906_bib23","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/lt.23711","article-title":"Conversion from Prograf to Advagraf in adolescents with stable liver transplants: comparative pharmacokinetics and 1-year follow-up","volume":"19","author":"Carcas-Sansu\u00e1n","year":"2013","journal-title":"Liver Transplant."},{"key":"10.1016\/j.cbi.2024.110906_bib24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3390\/pharmaceutics14020354","article-title":"Pharmacogene variants associated with liver transplant in a twelve-year clinical follow-up","volume":"14","author":"Sendra","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.cbi.2024.110906_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/FTD.0b013e3182a94e65","article-title":"Genotype and allele frequencies of drug-metabolizing enzymes and drug transporter genes affecting immunosuppressants in the Spanish white population","volume":"36","author":"Bos\u00f3","year":"2014","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.cbi.2024.110906_bib26","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1365-2125.2009.03461.x","article-title":"Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant","volume":"68","author":"Hawwa","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110906_bib40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/tpj.2016.49","article-title":"Effect of ABCB1 diplotype on tacrolimus disposition in renal recipients depends on CYP3A5 and CYP3A4 genotype","volume":"17","author":"Vanhove","year":"2017","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.cbi.2024.110906_bib27","first-page":"1093","article-title":"Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients","volume":"28","author":"Provenzani","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.cbi.2024.110906_bib28","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2217\/pgs-2022-0180","article-title":"Impact of genetic polymorphisms on tacrolimus trough blood concentration in Chinese liver transplant recipients","volume":"24","author":"Maseko","year":"2023","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cbi.2024.110906_bib29","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.apsb.2019.06.012","article-title":"PXR: a center of transcriptional regulation in cancer","volume":"10","author":"Xing","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cbi.2024.110906_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.intimp.2018.02.005","article-title":"Donor and recipient P450 gene polymorphisms influence individual pharmacological effects of tacrolimus in Chinese liver transplantation patients","volume":"57","author":"Liu","year":"2018","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.cbi.2024.110906_bib31","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1111\/bcp.14034","article-title":"The impact of liver transplant recipient and donor genetic variability on tacrolimus exposure and transplant outcome","volume":"85","author":"Coller","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110906_bib32","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1111\/bcp.14110","article-title":"Toward a robust tool for pharmacokinetic-based personalization of treatment with tacrolimus in solid organ transplantation: a model-based meta-analysis approach","volume":"85","author":"Nanga","year":"2019","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2024.110906_bib33","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1177\/1078155220959416","article-title":"Initial tacrolimus weight-based dosing strategy in allogeneic hematopoietic stem-cell transplantation","volume":"27","author":"Soskind","year":"2021","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.cbi.2024.110906_bib34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/jorc.12339","article-title":"Body weight-based initial dosing of tacrolimus in renal transplantation: is this an ideal approach?","volume":"47","author":"Chinnadurai","year":"2021","journal-title":"J. Ren. Care"},{"key":"10.1016\/j.cbi.2024.110906_bib35","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/ctr.12736","article-title":"Routine prophylaxis with proton pump inhibitors and post-transplant complications in kidney transplant recipients undergoing early corticosteroid withdrawal","volume":"30","author":"Courson","year":"2016","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.cbi.2024.110906_bib36","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2217\/pgs-2018-0003","article-title":"CYP3A pharmacogenetic association with tacrolimus pharmacokinetics differs based on route of drug administration","volume":"19","author":"Pasternak","year":"2018","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.cbi.2024.110906_bib37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1124\/dmd.108.025833","article-title":"Impact of intestinal CYP2C19 genotypes on the interaction between tacrolimus and omeprazole, but not lansoprazole, in adult living-donor liver transplant patients","volume":"37","author":"Hosohata","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2024.110906_bib38","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2710.2010.01163.x","article-title":"Pharmacogenetic determinants for interindividual difference of tacrolimus pharmacokinetics 1 year after renal transplantation","volume":"36","author":"Miura","year":"2011","journal-title":"J. Clin. Pharm. Therapeut."},{"key":"10.1016\/j.cbi.2024.110906_bib39","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/cpt.2015","article-title":"Clinical pharmacogenetics implementation Consortium (CPIC) guideline for CYP2C19 and proton pump inhibitor dosing","volume":"109","author":"Lima","year":"2021","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724000528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279724000528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:14:43Z","timestamp":1757859283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279724000528"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":40,"alternative-id":["S0009279724000528"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110906","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetic interactions between tacrolimus and Wuzhi capsule in liver transplant recipients: Genetic polymorphisms affect the drug interaction","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2024.110906","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110906"}}